Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
91.03 EUR | +1.02% | +2.79% | +1.44% |
03:10pm | Charles River Laboratories, Sanofi Collaborating to Develop Non-Animal Virtual Control Groups for Preclinical Trials | MT |
01:28pm | SANOFI : UBS reiterates its Buy rating | ZD |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.44% | 123B | |
+42.56% | 748B | |
+34.06% | 598B | |
-5.51% | 356B | |
+17.93% | 325B | |
+4.65% | 283B | |
+17.37% | 245B | |
+9.11% | 211B | |
-4.09% | 209B | |
+2.59% | 166B |
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- Transcript : Sanofi Presents at Bank of America Health Care Conference 2024, May-15-2024 08